Found: 5
Select item for more details and to access through your institution.
Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 9, p. 1613, doi. 10.1007/s00432-015-1924-3
- By:
- Publication type:
- Article
Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex.
- Published in:
- Cancers, 2014, v. 6, n. 1, p. 166, doi. 10.3390/cancers6010166
- By:
- Publication type:
- Article
A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, ...
- Published in:
- Carcinogenesis, 2012, v. 33, n. 5, p. 1004, doi. 10.1093/carcin/bgs120
- By:
- Publication type:
- Article
Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-342
- By:
- Publication type:
- Article
Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth.
- Published in:
- 2013
- By:
- Publication type:
- journal article